Navigating Financial and Tech Futures in Healthcare
Ken Londoner on Favorable Environments: From $3.5B fund oversight to BioSig’s NASDAQ listing, he outlines ROI pathways via subscription models addressing cardiac unmet needs, aligning with policy incentives for demographic-driven healthcare scalability. His Wall Street-to-biotech insights support compliant growth in aging populations, fostering job creation through strategic pivots.
Stream the episode and collaborate with USD Discovery District on evidence-based initiatives enhancing economic resilience in medtech.